We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Encompass Health (EHC) Q1: Wall Street Projections for Key Metrics
Read MoreHide Full Article
In its upcoming report, Encompass Health (EHC - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.93 per share, reflecting an increase of 5.7% compared to the same period last year. Revenues are forecasted to be $1.27 billion, representing a year-over-year increase of 9.5%.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some Encompass Health metrics that Wall Street analysts commonly model and monitor.
The collective assessment of analysts points to an estimated 'Revenues- Inpatient Rehabilitation' of $1.25 billion. The estimate points to a change of +9.8% from the year-ago quarter.
The average prediction of analysts places 'Revenues- Outpatient and other' at $27.56 million. The estimate points to a change of +5.2% from the year-ago quarter.
The consensus estimate for 'Net patient revenue per discharge' stands at $20,895.64. The estimate compares to the year-ago value of $20,415.
Analysts expect 'Total Discharges' to come in at 59,601. Compared to the current estimate, the company reported 55,557 in the same quarter of the previous year.
Shares of Encompass Health have experienced a change of +5.5% in the past month compared to the -4.2% move of the Zacks S&P 500 composite. With a Zacks Rank #2 (Buy), EHC is expected to outperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Insights Into Encompass Health (EHC) Q1: Wall Street Projections for Key Metrics
In its upcoming report, Encompass Health (EHC - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.93 per share, reflecting an increase of 5.7% compared to the same period last year. Revenues are forecasted to be $1.27 billion, representing a year-over-year increase of 9.5%.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some Encompass Health metrics that Wall Street analysts commonly model and monitor.
The collective assessment of analysts points to an estimated 'Revenues- Inpatient Rehabilitation' of $1.25 billion. The estimate points to a change of +9.8% from the year-ago quarter.
The average prediction of analysts places 'Revenues- Outpatient and other' at $27.56 million. The estimate points to a change of +5.2% from the year-ago quarter.
The consensus estimate for 'Net patient revenue per discharge' stands at $20,895.64. The estimate compares to the year-ago value of $20,415.
Analysts expect 'Total Discharges' to come in at 59,601. Compared to the current estimate, the company reported 55,557 in the same quarter of the previous year.
View all Key Company Metrics for Encompass Health here>>>
Shares of Encompass Health have experienced a change of +5.5% in the past month compared to the -4.2% move of the Zacks S&P 500 composite. With a Zacks Rank #2 (Buy), EHC is expected to outperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>